ECL (Ecolab Inc.) Stock Financials & Earnings | Market Cap Arena

ECL (Ecolab Inc.) Stock Financials & Earnings | Market Cap Arena

ECLEcolab Inc.

Mkt Cap$81B

Basic Materials·Chemicals - Specialty·🇺🇸 United States·NYSE

Revenue (TTM)$16.1B

Net Income (TTM)$2.1B

EPS (TTM)$7.28

Free Cash Flow (TTM)$1.9B

Gross Margin44.5%

Op. Margin17.7%

Net Margin12.9%

FCF Margin11.8%

P/S Ratio (TTM)5.0x

P/E Ratio (TTM)38.8x

YoY Rev Growth+2.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$3.6B	$1.4B	$405M
Q2 23	$3.9B	$1.5B	$519M
Q3 23	$4.0B	$1.6B	$624M
Q4 23	$3.9B	$1.7B	$614M
Q1 24	$3.8B	$1.6B	$547M
Q2 24	$4.0B	$1.7B	$673M
Q3 24	$4.0B	$1.7B	$707M
Q4 24	$4.0B	$1.7B	$686M
Q1 25	$3.7B	$1.6B	$587M
Q2 25	$4.0B	$1.8B	$710M
Q3 25	$4.2B	$1.9B	$760M
Q4 25	$4.2B	$1.8B	$786M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	5.6x	69.8x
Q2 23	5.5x	68.6x
Q3 23	5.3x	65.4x
Q4 23	5.3x	58.7x
Q1 24	5.2x	51.9x
Q2 24	5.2x	47.0x
Q3 24	5.1x	39.4x
Q4 24	5.1x	38.1x
Q1 25	5.1x	38.3x
Q2 25	5.1x	37.7x
Q3 25	5.1x	40.6x
Q4 25	5.0x	38.8x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$198M	$25M
Q2 23	$573M	$401M
Q3 23	$788M	$621M
Q4 23	$853M	$590M
Q1 24	$649M	$448M
Q2 24	$611M	$414M
Q3 24	$787M	$550M
Q4 24	$767M	$407M
Q1 25	$369M	$132M
Q2 25	$702M	$485M
Q3 25	$791M	$530M
Q4 25	$1.1B	$758M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$174M
Q2 23	$172M
Q3 23	$167M
Q4 23	$263M
Q1 24	$202M
Q2 24	$197M
Q3 24	$236M
Q4 24	$360M
Q1 25	$238M
Q2 25	$217M
Q3 25	$262M
Q4 25	$332M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+9.3%	+6.9%
Q2 23	+7.6%	+3.4%
Q3 23	+7.9%	+2.1%
Q4 23	+7.3%	+6.4%
Q1 24	+5.0%	+1.2%
Q2 24	+3.5%	-0.6%
Q3 24	+1.0%	-1.3%
Q4 24	+1.7%	-0.2%
Q1 25	-1.5%	-3.0%
Q2 25	+1.0%	+0.1%
Q3 25	+4.2%	+3.4%
Q4 25	+4.8%	+2.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$31M	0.9%
Q2 23	$27M	0.7%
Q3 23	$15M	0.4%
Q4 23	$22M	0.6%
Q1 24	$47M	1.3%
Q2 24	$36M	0.9%
Q3 24	$27M	0.7%
Q4 24	$25M	0.6%
Q1 25	$42M	1.1%
Q2 25	$34M	0.8%
Q3 25	$34M	0.8%
Q4 25	$27M	0.6%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	—	$960M
Q2 23	—	$1.0B
Q3 23	—	$1.0B
Q4 23	$192M	$1.0B
Q1 24	—	$1.1B
Q2 24	—	$1.1B
Q3 24	—	$1.0B
Q4 24	$207M	$1.1B
Q1 25	—	$1.1B
Q2 25	—	$1.1B
Q3 25	—	$1.1B
Q4 25	—	$1.1B

Revenue Segments

Quarter	Global Healthcare and Life Sciences	Global Industrial	Global Institutional and Specialty	Other	Global Pest Elimination	Global Life Sciences	Global Water
Q1 23	$380M	$1.7B	$1.1B	$330M	—	—	—
Q2 23	$391M	$1.8B	$1.3B	$364M	—	—	—
Q3 23	$406M	$1.8B	$1.3B	$382M	—	—	—
Q4 23	$400M	$1.8B	$1.3B	$368M	—	—	—
Q1 24	$383M	$1.8B	$1.3B	—	$267M	—	—
Q2 24	$395M	$2.0B	$1.4B	—	$297M	—	—
Q3 24	$334M	$2.0B	$1.4B	—	$309M	—	—
Q4 24	$322M	$2.1B	$1.4B	—	$295M	—	—
Q1 25	—	—	$1.4B	—	$281M	$170M	$1.8B
Q2 25	—	—	$1.5B	—	$317M	$186M	$2.0B
Q3 25	—	—	$1.6B	—	$332M	$185M	$2.1B
Q4 25	—	—	$1.5B	—	$317M	$207M	$2.1B

Revenue by Geography

Quarter	Asia Pacific	C [N]	Europe	Latin America	Middle East And Africa	United States	Canada
Q1 23	$311M	$157M	$737M	$218M	$126M	$2.0B	—
Q2 23	$327M	$172M	$819M	$252M	$133M	$2.1B	—
Q3 23	$325M	$165M	$838M	$265M	$142M	$2.2B	—
Q4 23	$333M	$176M	$825M	$280M	$152M	$1.7B	$453M
Q1 24	$321M	$167M	$763M	$260M	$122M	$2.0B	$112M
Q2 24	$325M	$170M	$823M	$265M	$139M	$2.1B	$118M
Q3 24	$325M	$175M	$834M	$264M	$142M	$2.1B	$125M
Q4 24	$371M	$186M	$773M	$311M	$223M	$2.0B	$124M
Q1 25	$314M	$174M	$712M	$249M	$131M	$2.0B	$115M
Q2 25	$331M	$180M	$813M	$264M	$160M	$2.2B	$124M
Q3 25	$342M	$184M	$856M	$280M	$159M	$2.2B	$133M
Q4 25	$378M	$184M	$894M	$308M	$189M	$2.1B	$129M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$419M	$0	$419M
Q2 23	$554M	$0	$554M
Q3 23	$1.0B	$0	$1.0B
Q4 23	$920M	$0	$920M
Q1 24	$480M	$0	$480M
Q2 24	$384M	$0	$384M
Q3 24	$1.3B	$0	$1.3B
Q4 24	$1.3B	$0	$1.3B
Q1 25	$1.2B	$0	$1.2B
Q2 25	$1.9B	$0	$1.9B
Q3 25	$2.0B	$0	$2.0B
Q4 25	$646M	$0	$646M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	286M	+0.0%
Q2 23	286M	+0.1%
Q3 23	287M	+0.2%
Q4 23	287M	+0.1%
Q1 24	288M	+0.2%
Q2 24	287M	-0.3%
Q3 24	286M	-0.3%
Q4 24	286M	-0.1%
Q1 25	285M	-0.1%
Q2 25	285M	+0.0%
Q3 25	285M	+0.0%
Q4 25	284M	-0.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$304K	47K
FY 15	$288K	47K
FY 16	$277K	48K
FY 17	$286K	48K
FY 18	$299K	49K
FY 19	$250K	50K
FY 20	$268K	44K
FY 21	$271K	47K
FY 22	$302K	47K
FY 23	$319K	48K
FY 24	$328K	48K
FY 25	$335K	48K